Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Molecular Players in Hematologic Tumor Cell Trafficking.

Redondo-Muñoz J, García-Pardo A, Teixidó J.

Front Immunol. 2019 Feb 6;10:156. doi: 10.3389/fimmu.2019.00156. eCollection 2019. Review.

2.

Novel contribution of epigenetic changes to nuclear dynamics.

Dreger M, Madrazo E, Hurlstone A, Redondo-Muñoz J.

Nucleus. 2019 Dec;10(1):42-47. doi: 10.1080/19491034.2019.1580100.

3.

G9a Correlates with VLA-4 Integrin and Influences the Migration of Childhood Acute Lymphoblastic Leukemia Cells.

Madrazo E, Ruano D, Abad L, Alonso-Gómez E, Sánchez-Valdepeñas C, González-Murillo Á, Ramírez M, Redondo-Muñoz J.

Cancers (Basel). 2018 Sep 12;10(9). pii: E325. doi: 10.3390/cancers10090325.

4.

WDR5 modulates cell motility and morphology and controls nuclear changes induced by a 3D environment.

Wang P, Dreger M, Madrazo E, Williams CJ, Samaniego R, Hodson NW, Monroy F, Baena E, Sánchez-Mateos P, Hurlstone A, Redondo-Muñoz J.

Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):8581-8586. doi: 10.1073/pnas.1719405115. Epub 2018 Jul 9.

5.

Inside the Cell: Integrins as New Governors of Nuclear Alterations?

Madrazo E, Conde AC, Redondo-Muñoz J.

Cancers (Basel). 2017 Jul 6;9(7). pii: E82. doi: 10.3390/cancers9070082. Review.

6.

Integrin α4β1 controls G9a activity that regulates epigenetic changes and nuclear properties required for lymphocyte migration.

Zhang X, Cook PC, Zindy E, Williams CJ, Jowitt TA, Streuli CH, MacDonald AS, Redondo-Muñoz J.

Nucleic Acids Res. 2016 Apr 20;44(7):3031-44. doi: 10.1093/nar/gkv1348. Epub 2015 Dec 10.

7.

Phosphoinositide 3-kinase beta protects nuclear envelope integrity by controlling RCC1 localization and Ran activity.

Redondo-Muñoz J, Pérez-García V, Rodríguez MJ, Valpuesta JM, Carrera AC.

Mol Cell Biol. 2015 Jan;35(1):249-63. doi: 10.1128/MCB.01184-14. Epub 2014 Oct 27.

8.

Phosphoinositide 3-kinase p85beta regulates invadopodium formation.

Cariaga-Martínez AE, Cortés I, García E, Pérez-García V, Pajares MJ, Idoate MA, Redondo-Muñóz J, Antón IM, Carrera AC.

Biol Open. 2014 Sep 12;3(10):924-36. doi: 10.1242/bio.20148185.

9.

Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity.

Pérez-García V, Redondo-Muñoz J, Kumar A, Carrera AC.

Mol Cell Biol. 2014 Sep 15;34(18):3359-73. doi: 10.1128/MCB.00167-14. Epub 2014 Jun 23.

10.

The dioxin receptor controls β1 integrin activation in fibroblasts through a Cbp-Csk-Src pathway.

Rey-Barroso J, Colo GP, Alvarez-Barrientos A, Redondo-Muñoz J, Carvajal-González JM, Mulero-Navarro S, García-Pardo A, Teixidó J, Fernandez-Salguero PM.

Cell Signal. 2013 Apr;25(4):848-59. doi: 10.1016/j.cellsig.2013.01.010. Epub 2013 Jan 16.

PMID:
23333462
11.

Phosphoinositide 3-kinase beta controls replication factor C assembly and function.

Redondo-Muñoz J, Rodríguez MJ, Silió V, Pérez-García V, Valpuesta JM, Carrera AC.

Nucleic Acids Res. 2013 Jan;41(2):855-68. doi: 10.1093/nar/gks1095. Epub 2012 Nov 21.

12.

Phosphoinositide 3-kinase β regulates chromosome segregation in mitosis.

Silió V, Redondo-Muñoz J, Carrera AC.

Mol Biol Cell. 2012 Dec;23(23):4526-42. doi: 10.1091/mbc.E12-05-0371. Epub 2012 Oct 10.

13.

Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.

García-Bernal D, Redondo-Muñoz J, Dios-Esponera A, Chèvre R, Bailón E, Garayoa M, Arellano-Sánchez N, Gutierrez NC, Hidalgo A, García-Pardo A, Teixidó J.

J Pathol. 2013 Jan;229(1):36-48. doi: 10.1002/path.4066.

PMID:
22711564
14.

Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival.

Kumar A, Redondo-Muñoz J, Perez-García V, Cortes I, Chagoyen M, Carrera AC.

Mol Cell Biol. 2011 May;31(10):2122-33. doi: 10.1128/MCB.01313-10. Epub 2011 Mar 7.

15.

Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.

Redondo-Muñoz J, Escobar-Díaz E, Hernández Del Cerro M, Pandiella A, Terol MJ, García-Marco JA, García-Pardo A.

Clin Cancer Res. 2010 Sep 1;16(17):4382-91. doi: 10.1158/1078-0432.CCR-10-0072. Epub 2010 Jun 9.

16.

Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain.

Redondo-Muñoz J, Ugarte-Berzal E, Terol MJ, Van den Steen PE, Hernández del Cerro M, Roderfeld M, Roeb E, Opdenakker G, García-Marco JA, García-Pardo A.

Cancer Cell. 2010 Feb 17;17(2):160-72. doi: 10.1016/j.ccr.2009.12.044.

17.

VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration.

Ugarte-Berzal E, Redondo-Muñoz J, Eroles P, Del Cerro MH, García-Marco JA, Terol MJ, García-Pardo A.

Blood. 2010 Jan 28;115(4):846-9. doi: 10.1182/blood-2009-08-239426. Epub 2009 Nov 19.

18.

Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.

Redondo-Muñoz J, Ugarte-Berzal E, García-Marco JA, del Cerro MH, Van den Steen PE, Opdenakker G, Terol MJ, García-Pardo A.

Blood. 2008 Jul 1;112(1):169-78. doi: 10.1182/blood-2007-08-109249. Epub 2008 Mar 7.

20.

MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration.

Redondo-Muñoz J, Escobar-Díaz E, Samaniego R, Terol MJ, García-Marco JA, García-Pardo A.

Blood. 2006 Nov 1;108(9):3143-51. Epub 2006 Jul 13.

Supplemental Content

Loading ...
Support Center